Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urothelial Cancer × Everolimus × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 67 Kidney Neoplasms 24 Prostatic Neoplasms 16 Neoplasm Metastasis 9 Urinary Bladder Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma 4 Breast Neoplasms 4 Neuroendocrine Tumors 3 Neoplasms 3 Carcinoma, Transitional Cell 3 Adenocarcinoma 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Pheochromocytoma 2 Clear-cell metastatic renal cell carcinoma 2 Urothelial Cancer 1 Tuberous Sclerosis 1 Thrombocytosis 1 Somatostatinoma 1 Renal Cell Cancer Metastatic 1 Prostate Cancer Patients With Detectable PSA Following Prostatectomy 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Kidney, Autosomal Dominant 1 Paraganglioma 1 Pancreatic Neoplasms 1 Neoplastic Syndromes, Hereditary 1 NOG-Related-Symphalangism Spectrum Disorder 1 Myeloproliferative Disorders 1

Interventions

Gemcitabine 4 Cisplatin 4 Carboplatin 3 pembrolizumab 2 erdafitinib 2 durvalumab 2 vinflunine 1 tremelimumab 1 niraparib 1 enfortumab vedotin 1 cabozantinib 1 avelumab 1 atezolizumab 1 Tiragolumab 1 Sunitinib 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Midazolam 1 Metformin 1 Ipilimumab 1 Everolimus 1 Docetaxel 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01801137 2016-06-21

AFINIVEST

Hopital Foch

Phase 2 Completed

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡